The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral small molecule modulators of p300/CBP to reprogram cancer cells and reactivate the p53 pathway in HPV-associated carcinomas.
 
Ulrich Kessler
Employment - Intarcia Therapeutics
Leadership - Intarcia Therapeutics
Stock and Other Ownership Interests - Intarcia Therapeutics
Patents, Royalties, Other Intellectual Property - Intarcia Therapeutics
 
Valentino Cattori
Employment - Intarcia Therapeutics
Patents, Royalties, Other Intellectual Property - Inthera Bioscience G
 
Marc Labelle
Employment - ML Pharma Consulting
Leadership - ML Pharma Consulting
Stock and Other Ownership Interests - ML Pharma Consulting
Consulting or Advisory Role - Intarcia Therapeutics
Research Funding - Intarcia Therapeutics
Patents, Royalties, Other Intellectual Property - Intarcia Therapeutics
 
Bernd Hentsch
Consulting or Advisory Role - Intarcia Therapeutics